5-HT6 receptor agonist and antagonist modulates ICV-STZ-induced memory impairment in rats.
Anand M BokareMandar BhondeRajan GoelYogendra NayakPublished in: Psychopharmacology (2018)
The findings in this study support the therapeutic potential of 5-HT6 receptor ligands in the treatment of cognitive dysfunction.